APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Gummies

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Immune Gummies Industry Growth and Trends Forecast to 2032

13 August 2026102 pages

Choose your research edition.

Industry ResearchImmune Gummies Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Gummies Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Immune Gummies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Gummies Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Gummies Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Immune Gummies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Immune Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Immune Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immune Gummies include Pfizer Inc, Schiff Vitamins, OLLY Public Benefit Corporation, Alani Nu, Windmill Health Products, Nature's Way Products, Chapter One, Hims, Inc and Sambucol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Immune Gummies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Immune Gummies market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Immune Gummies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Immune Gummies.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Immune Gummies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Immune Gummies Market by Company

Pfizer Inc

Schiff Vitamins

OLLY Public Benefit Corporation

Alani Nu

Windmill Health Products

Nature's Way Products

Chapter One

Hims, Inc

Sambucol

Jamieson

Blackmores

GNC Holdings

Immune Gummies Segment by Type

60-count

120-count

Other

Immune Gummies Segment by Application

Online Shopping

Retailers

Supermarket

Other

Immune Gummies Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Gummies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Gummies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Gummies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immune Gummies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Immune Gummies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 60-count Table 2. Major Company of 120-count Table 3. Major Company of Other Table 4. Global Immune Gummies Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Immune Gummies Sales by Type (2021-2026) & (k units) Table 6. Global Immune Gummies Sales Market Share in Volume by Type (2021-2026) Table 7. Global Immune Gummies Sales by Type (2021-2026) & (US$ Million) Table 8. Global Immune Gummies Sales Market Share in Value by Type (2021-2026) Table 9. Global Immune Gummies Price by Type (2021-2026) & (USD/unit) Table 10. Global Immune Gummies Sales by Type (2027-2032) & (k units) Table 11. Global Immune Gummies Sales Market Share in Volume by Type (2027-2032) Table 12. Global Immune Gummies Sales by Type (2027-2032) & (US$ Million) Table 13. Global Immune Gummies Sales Market Share in Value by Type (2027-2032) Table 14. Global Immune Gummies Price by Type (2027-2032) & (USD/unit) Table 15. North America Immune Gummies Sales by Type (2021-2026) & (k units) Table 16. North America Immune Gummies Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Immune Gummies Sales by Type (2021-2026) & (k units) Table 18. Europe Immune Gummies Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Immune Gummies Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Immune Gummies Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Immune Gummies Sales by Type (2021-2026) & (k units) Table 22. Latin America Immune Gummies Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Immune Gummies Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Immune Gummies Sales by Type (2021-2026) & (US$ Million) Table 25. Immune Gummies Industry Trends Table 26. Immune Gummies Industry Drivers Table 27. Immune Gummies Industry Opportunities and Challenges Table 28. Immune Gummies Industry Restraints Table 29. Global Immune Gummies Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Immune Gummies Revenue Market Share by Company (2021-2026) Table 31. Global Immune Gummies Sales by Company (2021-2026) & (k units) Table 32. Global Immune Gummies Sales Share by Company (2021-2026) Table 33. Global Immune Gummies Market Price by Company (2021-2026) & (USD/unit) Table 34. Global Immune Gummies Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Immune Gummies Major Company Production Sites and Headquarters Table 36. Global Immune Gummies Company, Product Type & Application Table 37. Global Immune Gummies Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Immune Gummies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Immune Gummies Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Immune Gummies Sales by Region (2021-2026) & (k units) Table 42. Global Immune Gummies Sales Market Share in Volume by Region (2021-2026) Table 43. Global Immune Gummies Sales by Region (2021-2026) & (US$ Million) Table 44. Global Immune Gummies Sales Market Share in Value by Region (2021-2026) Table 45. Global Immune Gummies Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 46. Global Immune Gummies Sales by Region (2027-2032) & (k units) Table 47. Global Immune Gummies Sales Market Share in Volume by Region (2027-2032) Table 48. Global Immune Gummies Sales by Region (2027-2032) & (US$ Million) Table 49. Global Immune Gummies Sales Market Share in Value by Region (2027-2032) Table 50. Global Immune Gummies Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 51. Global Immune Gummies Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Immune Gummies Sales by Application (2021-2026) & (k units) Table 53. Global Immune Gummies Sales Market Share in Volume by Application (2021-2026) Table 54. Global Immune Gummies Sales by Application (2021-2026) & (US$ Million) Table 55. Global Immune Gummies Sales Market Share in Value by Application (2021-2026) Table 56. Global Immune Gummies Price by Application (2021-2026) & (USD/unit) Table 57. Global Immune Gummies Sales by Application (2027-2032) & (k units) Table 58. Global Immune Gummies Sales Market Share in Volume by Application (2027-2032) Table 59. Global Immune Gummies Sales by Application (2027-2032) & (US$ Million) Table 60. Global Immune Gummies Sales Market Share in Value by Application (2027-2032) Table 61. Global Immune Gummies Price by Application (2027-2032) & (USD/unit) Table 62. North America Immune Gummies Sales by Application (2021-2026) & (k units) Table 63. North America Immune Gummies Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Immune Gummies Sales by Application (2021-2026) & (k units) Table 65. Europe Immune Gummies Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Immune Gummies Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Immune Gummies Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Immune Gummies Sales by Application (2021-2026) & (k units) Table 69. Latin America Immune Gummies Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Immune Gummies Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Immune Gummies Sales by Application (2021-2026) & (US$ Million) Table 72. Pfizer Inc Company Information Table 73. Pfizer Inc Business Overview Table 74. Pfizer Inc Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Pfizer Inc Immune Gummies Product Portfolio Table 76. Pfizer Inc Recent Development Table 77. Schiff Vitamins Company Information Table 78. Schiff Vitamins Business Overview Table 79. Schiff Vitamins Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Schiff Vitamins Immune Gummies Product Portfolio Table 81. Schiff Vitamins Recent Development Table 82. OLLY Public Benefit Corporation Company Information Table 83. OLLY Public Benefit Corporation Business Overview Table 84. OLLY Public Benefit Corporation Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. OLLY Public Benefit Corporation Immune Gummies Product Portfolio Table 86. OLLY Public Benefit Corporation Recent Development Table 87. Alani Nu Company Information Table 88. Alani Nu Business Overview Table 89. Alani Nu Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Alani Nu Immune Gummies Product Portfolio Table 91. Alani Nu Recent Development Table 92. Windmill Health Products Company Information Table 93. Windmill Health Products Business Overview Table 94. Windmill Health Products Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Windmill Health Products Immune Gummies Product Portfolio Table 96. Windmill Health Products Recent Development Table 97. Nature's Way Products Company Information Table 98. Nature's Way Products Business Overview Table 99. Nature's Way Products Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Nature's Way Products Immune Gummies Product Portfolio Table 101. Nature's Way Products Recent Development Table 102. Chapter One Company Information Table 103. Chapter One Business Overview Table 104. Chapter One Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Chapter One Immune Gummies Product Portfolio Table 106. Chapter One Recent Development Table 107. Hims, Inc Company Information Table 108. Hims, Inc Business Overview Table 109. Hims, Inc Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Hims, Inc Immune Gummies Product Portfolio Table 111. Hims, Inc Recent Development Table 112. Sambucol Company Information Table 113. Sambucol Business Overview Table 114. Sambucol Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Sambucol Immune Gummies Product Portfolio Table 116. Sambucol Recent Development Table 117. Jamieson Company Information Table 118. Jamieson Business Overview Table 119. Jamieson Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Jamieson Immune Gummies Product Portfolio Table 121. Jamieson Recent Development Table 122. Blackmores Company Information Table 123. Blackmores Business Overview Table 124. Blackmores Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Blackmores Immune Gummies Product Portfolio Table 126. Blackmores Recent Development Table 127. GNC Holdings Company Information Table 128. GNC Holdings Business Overview Table 129. GNC Holdings Immune Gummies Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. GNC Holdings Immune Gummies Product Portfolio Table 131. GNC Holdings Recent Development Table 132. North America Immune Gummies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 133. North America Immune Gummies Sales by Country (2021-2026) & (k units) Table 134. North America Immune Gummies Sales Market Share by Country (2021-2026) Table 135. North America Immune Gummies Sales Forecast by Country (2027-2032) & (k units) Table 136. North America Immune Gummies Sales Market Share Forecast by Country (2027-2032) Table 137. North America Immune Gummies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. North America Immune Gummies Market Size by Country (2021-2026) & (US$ Million) Table 139. North America Immune Gummies Market Share by Country (2021-2026) Table 140. North America Immune Gummies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. North America Immune Gummies Market Share Forecast by Country (2027-2032) Table 142. Europe Immune Gummies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 143. Europe Immune Gummies Sales by Country (2021-2026) & (k units) Table 144. Europe Immune Gummies Sales Market Share by Country (2021-2026) Table 145. Europe Immune Gummies Sales Forecast by Country (2027-2032) & (k units) Table 146. Europe Immune Gummies Sales Market Share Forecast by Country (2027-2032) Table 147. Europe Immune Gummies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Europe Immune Gummies Market Size by Country (2021-2026) & (US$ Million) Table 149. Europe Immune Gummies Market Share by Country (2021-2026) Table 150. Europe Immune Gummies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Europe Immune Gummies Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Immune Gummies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Immune Gummies Sales by Country (2021-2026) & (k units) Table 154. Asia-Pacific Immune Gummies Sales Market Share by Country (2021-2026) Table 155. Asia-Pacific Immune Gummies Sales Forecast by Country (2027-2032) & (k units) Table 156. Asia-Pacific Immune Gummies Sales Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Immune Gummies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Immune Gummies Market Size by Country (2021-2026) & (US$ Million) Table 159. Asia-Pacific Immune Gummies Market Share by Country (2021-2026) Table 160. Asia-Pacific Immune Gummies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Asia-Pacific Immune Gummies Market Share Forecast by Country (2027-2032) Table 162. Latin America Immune Gummies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 163. Latin America Immune Gummies Sales by Country (2021-2026) & (k units) Table 164. Latin America Immune Gummies Sales Market Share by Country (2021-2026) Table 165. Latin America Immune Gummies Sales Forecast by Country (2027-2032) & (k units) Table 166. Latin America Immune Gummies Sales Market Share Forecast by Country (2027-2032) Table 167. Latin America Immune Gummies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Latin America Immune Gummies Market Size by Country (2021-2026) & (US$ Million) Table 169. Latin America Immune Gummies Market Share by Country (2021-2026) Table 170. Latin America Immune Gummies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Latin America Immune Gummies Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Immune Gummies Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Immune Gummies Sales by Country (2021-2026) & (k units) Table 174. Middle East and Africa Immune Gummies Sales Market Share by Country (2021-2026) Table 175. Middle East and Africa Immune Gummies Sales Forecast by Country (2027-2032) & (k units) Table 176. Middle East and Africa Immune Gummies Sales Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Immune Gummies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Immune Gummies Market Size by Country (2021-2026) & (US$ Million) Table 179. Middle East and Africa Immune Gummies Market Share by Country (2021-2026) Table 180. Middle East and Africa Immune Gummies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Middle East and Africa Immune Gummies Market Share Forecast by Country (2027-2032) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Immune Gummies Distributors List Table 185. Immune Gummies Customers List Table 186. Research Programs/Design for This Report Table 187. Authors List of This Report Table 188. Secondary Sources Table 189. Primary Sources List of Figures Figure 1. Immune Gummies Image Figure 2. Global Immune Gummies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Gummies Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune Gummies Sales (2021-2032) & (k units) Figure 5. 60-count Image Figure 6. Global 60-count Sales YoY Growth (2021-2032) & (k units) Figure 7. 120-count Image Figure 8. Global 120-count Sales YoY Growth (2021-2032) & (k units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Immune Gummies Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Immune Gummies Market Share by Type 2025 VS 2032 Figure 13. North America Immune Gummies Sales Market Share in Volume by Type in 2025 Figure 14. North America Immune Gummies Sales Market Share in Value by Type in 2025 Figure 15. Europe Immune Gummies Sales Market Share in Volume by Type in 2025 Figure 16. Europe Immune Gummies Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Immune Gummies Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Immune Gummies Sales Market Share in Value by Type in 2025 Figure 19. Latin America Immune Gummies Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Immune Gummies Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Immune Gummies Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Immune Gummies Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Immune Gummies Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Online Shopping Image Figure 26. Global Online Shopping Sales YoY Growth (2021-2032) & (k units) Figure 27. Retailers Image Figure 28. Global Retailers Sales YoY Growth (2021-2032) & (k units) Figure 29. Supermarket Image Figure 30. Global Supermarket Sales YoY Growth (2021-2032) & (k units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Immune Gummies Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Immune Gummies Market Share by Application 2025 VS 2032 Figure 35. North America Immune Gummies Sales Market Share in Volume by Application in 2025 Figure 36. North America Immune Gummies Sales Market Share in Value by Application in 2025 Figure 37. Europe Immune Gummies Sales Market Share in Volume by Application in 2025 Figure 38. Europe Immune Gummies Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Immune Gummies Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Immune Gummies Sales Market Share in Value by Application in 2025 Figure 41. Latin America Immune Gummies Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Immune Gummies Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Immune Gummies Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Immune Gummies Sales Market Share in Value by Application in 2025 Figure 45. North America Immune Gummies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Immune Gummies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Immune Gummies Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Immune Gummies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Immune Gummies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Immune Gummies Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Immune Gummies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Immune Gummies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Immune Gummies Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Immune Gummies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Immune Gummies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Immune Gummies Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Immune Gummies Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Immune Gummies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Immune Gummies Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Immune Gummies Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Immune Gummies Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 60-count
  • 120-count
  • Other
Applications
  • Online Shopping
  • Retailers
  • Supermarket
  • Other
Companies covered
  • Pfizer Inc
  • Schiff Vitamins
  • OLLY Public Benefit Corporation
  • Alani Nu
  • Windmill Health Products
  • Nature's Way Products
  • Chapter One
  • Hims, Inc
  • Sambucol
  • Jamieson
  • Blackmores
  • GNC Holdings

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Immune Gummies Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Immune Gummies Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Immune Gummies Market by Type
  6. 1.3.1 60-count
  7. 1.3.2 120-count
  8. 1.3.3 Other
  9. 1.4 Global Immune Gummies Market Size by Type
  10. 1.4.1 Global Immune Gummies Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Immune Gummies Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Immune Gummies Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Immune Gummies Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Immune Gummies Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Immune Gummies Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Immune Gummies Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Immune Gummies Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Immune Gummies Industry Trends
  2. 2.2 Immune Gummies Industry Drivers
  3. 2.3 Immune Gummies Industry Opportunities and Challenges
  4. 2.4 Immune Gummies Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Immune Gummies Revenue (2021-2026)
  2. 3.2 Global Top Players by Immune Gummies Sales (2021-2026)
  3. 3.3 Global Top Players by Immune Gummies Price (2021-2026)
  4. 3.4 Global Immune Gummies Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immune Gummies Major Company Production Sites & Headquarters
  6. 3.6 Global Immune Gummies Company, Product Type & Application
  7. 3.7 Global Immune Gummies Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immune Gummies Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immune Gummies Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immune Gummies Tier 1, Tier 2, and Tier 3
4 Immune Gummies Regional Status and Outlook
  1. 4.1 Global Immune Gummies Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Immune Gummies Historic Market Size by Region
  3. 4.2.1 Global Immune Gummies Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Immune Gummies Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Immune Gummies Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Immune Gummies Forecasted Market Size by Region
  7. 4.3.1 Global Immune Gummies Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Immune Gummies Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Immune Gummies Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Immune Gummies by Application
  1. 5.1 Immune Gummies Market by Application
  2. 5.1.1 Online Shopping
  3. 5.1.2 Retailers
  4. 5.1.3 Supermarket
  5. 5.1.4 Other
  6. 5.2 Global Immune Gummies Market Size by Application
  7. 5.2.1 Global Immune Gummies Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Immune Gummies Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Immune Gummies Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Immune Gummies Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Immune Gummies Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Immune Gummies Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Immune Gummies Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Immune Gummies Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Pfizer Inc
  2. 6.1.1 Pfizer Inc Company Information
  3. 6.1.2 Pfizer Inc Business Overview
  4. 6.1.3 Pfizer Inc Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Inc Immune Gummies Product Portfolio
  6. 6.1.5 Pfizer Inc Recent Developments
  7. 6.2 Schiff Vitamins
  8. 6.2.1 Schiff Vitamins Company Information
  9. 6.2.2 Schiff Vitamins Business Overview
  10. 6.2.3 Schiff Vitamins Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Schiff Vitamins Immune Gummies Product Portfolio
  12. 6.2.5 Schiff Vitamins Recent Developments
  13. 6.3 OLLY Public Benefit Corporation
  14. 6.3.1 OLLY Public Benefit Corporation Company Information
  15. 6.3.2 OLLY Public Benefit Corporation Business Overview
  16. 6.3.3 OLLY Public Benefit Corporation Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 OLLY Public Benefit Corporation Immune Gummies Product Portfolio
  18. 6.3.5 OLLY Public Benefit Corporation Recent Developments
  19. 6.4 Alani Nu
  20. 6.4.1 Alani Nu Company Information
  21. 6.4.2 Alani Nu Business Overview
  22. 6.4.3 Alani Nu Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Alani Nu Immune Gummies Product Portfolio
  24. 6.4.5 Alani Nu Recent Developments
  25. 6.5 Windmill Health Products
  26. 6.5.1 Windmill Health Products Company Information
  27. 6.5.2 Windmill Health Products Business Overview
  28. 6.5.3 Windmill Health Products Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Windmill Health Products Immune Gummies Product Portfolio
  30. 6.5.5 Windmill Health Products Recent Developments
  31. 6.6 Nature's Way Products
  32. 6.6.1 Nature's Way Products Company Information
  33. 6.6.2 Nature's Way Products Business Overview
  34. 6.6.3 Nature's Way Products Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Nature's Way Products Immune Gummies Product Portfolio
  36. 6.6.5 Nature's Way Products Recent Developments
  37. 6.7 Chapter One
  38. 6.7.1 Chapter One Company Information
  39. 6.7.2 Chapter One Business Overview
  40. 6.7.3 Chapter One Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Chapter One Immune Gummies Product Portfolio
  42. 6.7.5 Chapter One Recent Developments
  43. 6.8 Hims, Inc
  44. 6.8.1 Hims, Inc Company Information
  45. 6.8.2 Hims, Inc Business Overview
  46. 6.8.3 Hims, Inc Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hims, Inc Immune Gummies Product Portfolio
  48. 6.8.5 Hims, Inc Recent Developments
  49. 6.9 Sambucol
  50. 6.9.1 Sambucol Company Information
  51. 6.9.2 Sambucol Business Overview
  52. 6.9.3 Sambucol Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Sambucol Immune Gummies Product Portfolio
  54. 6.9.5 Sambucol Recent Developments
  55. 6.10 Jamieson
  56. 6.10.1 Jamieson Company Information
  57. 6.10.2 Jamieson Business Overview
  58. 6.10.3 Jamieson Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jamieson Immune Gummies Product Portfolio
  60. 6.10.5 Jamieson Recent Developments
  61. 6.11 Blackmores
  62. 6.11.1 Blackmores Company Information
  63. 6.11.2 Blackmores Business Overview
  64. 6.11.3 Blackmores Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Blackmores Immune Gummies Product Portfolio
  66. 6.11.5 Blackmores Recent Developments
  67. 6.12 GNC Holdings
  68. 6.12.1 GNC Holdings Company Information
  69. 6.12.2 GNC Holdings Business Overview
  70. 6.12.3 GNC Holdings Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GNC Holdings Immune Gummies Product Portfolio
  72. 6.12.5 GNC Holdings Recent Developments
7 North America by Country
  1. 7.1 North America Immune Gummies Sales by Country
  2. 7.1.1 North America Immune Gummies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Immune Gummies Sales by Country (2021-2026)
  4. 7.1.3 North America Immune Gummies Sales Forecast by Country (2027-2032)
  5. 7.2 North America Immune Gummies Market Size by Country
  6. 7.2.1 North America Immune Gummies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Immune Gummies Market Size by Country (2021-2026)
  8. 7.2.3 North America Immune Gummies Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Immune Gummies Sales by Country
  2. 8.1.1 Europe Immune Gummies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Immune Gummies Sales by Country (2021-2026)
  4. 8.1.3 Europe Immune Gummies Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Immune Gummies Market Size by Country
  6. 8.2.1 Europe Immune Gummies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Immune Gummies Market Size by Country (2021-2026)
  8. 8.2.3 Europe Immune Gummies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Immune Gummies Sales by Country
  2. 9.1.1 Asia-Pacific Immune Gummies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Immune Gummies Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Immune Gummies Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Immune Gummies Market Size by Country
  6. 9.2.1 Asia-Pacific Immune Gummies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Immune Gummies Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Immune Gummies Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Immune Gummies Sales by Country
  2. 10.1.1 South America Immune Gummies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Immune Gummies Sales by Country (2021-2026)
  4. 10.1.3 South America Immune Gummies Sales Forecast by Country (2027-2032)
  5. 10.2 South America Immune Gummies Market Size by Country
  6. 10.2.1 South America Immune Gummies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Immune Gummies Market Size by Country (2021-2026)
  8. 10.2.3 South America Immune Gummies Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Immune Gummies Sales by Country
  2. 11.1.1 Middle East and Africa Immune Gummies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Immune Gummies Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Immune Gummies Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Immune Gummies Market Size by Country
  6. 11.2.1 Middle East and Africa Immune Gummies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Immune Gummies Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Immune Gummies Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Immune Gummies Value Chain Analysis
  2. 12.1.1 Immune Gummies Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Immune Gummies Production Mode & Process
  7. 12.2 Immune Gummies Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Immune Gummies Distributors
  10. 12.2.3 Immune Gummies Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst